Journal Articles 2002 - pres.

    2002

  • Lenders J.W.M., K. Pacak, M.M. Walther, W.M. Linehan, M. Mannelli, P. Friberg, H.R. Keiser, D.S. Goldstein  and G. Eisenhofer. Biochemical diagnosis of pheochromocytoma: Which test is best? Journal of the American Medical Association 287: 1427-1434, 2002.
  • Eisenhofer, G., J.W.M. Lenders and K. Pacak. Choice of biochemical test for diagnosis of pheochromocytoma: Validation of plasma metanephrines. Current Hypertension Reports 4: 250-255, 2002.
  • Weise, M., D.P. Merke, K. Pacak, M.M. Walther and G. Eisenhofer. Utility of plasma free metanephrines for detecting childhood pheochromocytoma. Journal of Clinical Endocrinology and Metabolism 87: 1995-1960, 2002.
  • Franklin, S.L., G. Eisenhofer and M.E. Geffner. Simultaneous development of pheochromocytomas in prepubertal siblings with von Hippel-Lindau disease. Journal of Pediatrics  140: 625-628, 2002.
  • Pacak K., C.A. Koch and G. Eisenhofer. Current approaches and new advances in endocrine hypertension. Trends in Endocrinology and Metabolism 13: 96-97, 2002.
  • Charmandari, E., M. Weise, S.R. Bornstein, G. Eisenhofer, M.F. Keil, G.P. Chrousos and D.P. Merke. Children with adrenomedullary hypofunction due to congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance. Journal of Clinical Endocrinology and Metabolism 87: 2114-2120, 2002.
  • Charmandari, G. Eisenhofer, S.L. Mehlinger, A. Carlson, R. Wesley, M.F. Keil, G.P. Chrousos, M.I. New and D.P. Merke. Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism 87: 3031-3037, 2002.
  • Yoshida-Hiroi, M., M.J. Bradbury, G. Eisenhofer, N. Hiroi, W.W. Vale, G.E. Novotny, W.A. Scherbaum and S.R. Bornstein. Chromaffin Cell Function and Structure is Impaired in CRHR1-Null Mice. Molecular Psychiatry 7: 967-974 2002.
  • Kawamura, M., G. Eisenhofer, I.J. Kopin, P.F. Kador, Y.S. L.S.Fujisawa and S. Sato. Aldose Reductase as Aldehyde Scavenging Enzyme in Intraneural Metabolism of Norepinephrine in Human Sympathetic Ganglia. Autonomic Neuroscience 96: 131-139, 2002.
  • Petersson, M.J., B. Rundqvist, M. Johansson, G. Eisenhofer, G. Lambert, H. Herlitz, G. Jensen and P. Friberg. Increased cardiac sympathetic drive in renovascular hypertension. Journal of  Hypertension 20:1181-1187, 2002.
  • Patel, J., S.W. Coppack, D.S. Goldstein, J.M. Miles, and G. Eisenhofer. Norepinephrine spillover from human adipose tissue before and after a 72 hr fast.  Journal of Clinical Endocrinology and Metabolism 87: 3373-3377, 2002.                                                                                                                  
  • Weise, M., G. Eisenhofer, and D.P. Merke. Pubertal and gender-related changes in the sympathoadrenal system in healthy children Journal of Clinical Endocrinology and Metabolism 87: 5038-5043, 2002.
  • Elman, I., D.S. Goldstein, A.I. Green, G. Eisenhofer, C.J. Folio, C.S. Holmes, D. Pickar and A. Breier. Effects of risperidone on the peripheral noradrenergic system in patients with schizophrenia: A comparison with clozapine and placebo. Neuropsychopharmacology 27:293-300, 2002.
  • Goldstein, D.S., D. Robertson, M. Esler, S.E. Straus, and G. Eisenhofer. Dysautonomias: clinical disorders of the autonomic nervous system. Annals of Internal Medicine 137: 753-763, 2002.
  • Goldstein, D.S., C. Holmes, S.M. Frank, R. Dendi, R.O. Cannon, Y. Sharabi. M.D. Esler and G. Eisenhofer. Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes. Circulation 106: 2358-2365, 2002.
     

    2003

  • Eisenhofer, G., Editorial: biochemical diagnosis of pheochromocytoma — is it time to switch to plasma-free metanephrines? Journal of Clinical Endocrinology and Metabolism 88: 550-552, 2003.
  • Eisenhofer, G., D.S. Goldstein, M.M. Walther, P. Friberg, J.W. Lenders, H.R. Keiser, and K. Pacak. Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. Journal of Clinical Endocrinology and Metabolism 88: 2656-2666, 2003.
  • Eisenhofer, G., D.S. Goldstein, I.J. Kopin and J.R. Crout Pheochromocytoma: rediscovery as a catecholamine-metabolizing tumor. Endocrine Pathology 14: 193-212, 2003.
  • Brouwers, F.M., J.W.M. Lenders, G. Eisenhofer and K. Pacak. Pheochromocytoma as an endocrine emergency. Reviews in Endocrine & Metabolic Disorders. 4: 121-128, 2003.
  • Ilias, I., J. Yu, J.A. Carrasquillo, C.C. Chen, G. Eisenhofer, M. Whatley, B. McElroy and K. Pacak. Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. Journal of Clinical Endocrinology and Metabolism 88:4083-4087, 2003.
  • Koch, C.A., J.S.Rodbard, F.M. Brouwers, G. Eisenhofer, K. Pacak. Hypotension in a woman with a metastatic dopamine-secreting carotid body tumor. Endocrine Practice 9:310-314, 2003.
  • Eisenhofer, G., H. Tian, C. Holmes, J. Matsunaga, S. Roffler-Tarlov, and V.J. Hearing. Tyrosinase: a developmentally specific major determinant of peripheral dopamine. FASEB Journal 17: 1248-1255, 2003.
  • Goldstein, D.S., G. Eisenhofer, I.J. Kopin. Sources and significance of plasma levels of catechols and their metabolites in humans. Journal of Pharmacology and Experimental Therapeutics 305: 800-811, 2003.
  • Goldstein, D.S., C. Holmes, Y. Sharabi, S. Brentzel, and G. Eisenhofer. Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension. Neurology. 22: 1327-1332, 2003.
  • Bornstein, S.R., M. Yoshida-Hiroi, S. Sotiriou, M. Levine, H.G. Hartwig, R.L. Nussbaum, G. Eisenhofer. Impaired adrenal catecholamine system function in mice with deficiency of the ascorbic acid transporter (SVCT2) FASEB Journal 17: 1928-1930, 2003.  
     

    2004

  • Eisenhofer, G., I.J. Kopin, and D.S. Goldstein. Catecholamine metabolism: A contemporary view with implications for physiology and medicine. Pharmacological Reviews 56: 331-349, 2004.
  • Eisenhofer, G., T-T Huynh, K. Pacak, F.M. Brouwers, M.M. Walther, W. Marston Linehan, P.J. Munson, M. Mannelli, D.S. Goldstein, and Abdel G. Elkahloun. Distinct gene expression profiles in norepinephrine and epinephrine producing hereditary and sporadic pheochromocytomas: Activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome. Endocrine-Related Cancer 11: 897-911, 2004.
  • Eisenhofer, G., S.R. Bornstein, F.M. Brouwers, N.-K.V. Cheung, P.L. Dahia, R.R. deKrijger, T.J. Giordano, L.A. Greene, D.S. Goldstein, H. Lehnert, W.M. Manger, J.M. Maris, H.P.H. Neumann, K. Pacak, B.L. Shulkin, D.I. Smith, A.S. Tischler, and W.F. Young Jr. Malignant pheochromocytoma. Current status and initiatives for future progress. Endocrine-Related Cancer 11: 1-14, 2004.
  • Eisenhofer, G., J.W. Lenders and K. Pacak. Biochemical diagnosis of pheochromocytoma. Frontiers of Hormone Research 31: 76-106, 2004.
  • Pacak, K., G. Eisenhofer, and I. Ilias. Diagnostic imaging of pheochromocytoma. Frontiers of Hormone Research 31:107-120, 2004.
  • Schulz, C., G. Eisenhofer, and H. Lehnert. Principles of catecholamine biosynthesis, metabolism and release. Frontiers of Hormone Research 31: 1-25, 2004.
  • Pacak, K., G. Eisenhofer, and D.S. Goldstein. Functional imaging of endocrine tumors: Role of positron emission tomography. Endocrine Reviews 25: 568-580, 2004.
  • Goldstein D.S., G. Eisenhofer, J.A. Flynn, G. Wand, and, K. Pacak. Diagnosis and localization of pheochromocytoma. Hypertension 43: 907-910, 2004.
  • Manger, W.M. and Eisenhofer G. Pheochromocytoma: Diagnosis and management update. Current Hypertension Reports 6: 477-484, 2004.
  • Eldadah B.A., K. Pacak, G. Eisenhofer, C. Holmes, I.J. Kopin, and D.S. Goldstein. Cardiac uptake-1 inhibition by high circulating norepinephrine levels in patients with pheochromocytoma. Hypertension 43: 1227-1232, 2004.
  • Weise M., S.L. Mehlinger, B. Drinkard, E. Rawson, E. Charmandari, M. Hiroi, G. Eisenhofer, J.A. Yanovski, G.P. Chrousos, D.P. Merke. Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glucose elevation in response to high-intensity exercise. Journal of Clinical Endocrinology and Metabolism 89: 591-597, 2004.
  • Weise, M., B. Drinkard, S.L. Mehlinger, G. Eisenhofer, G.P. Chrousos and D.P. Merke. Stress dose of hydrocortisone  is not beneficial in patients with classic congenital adrenal hyperplasia undergoing short-term high-intensity exercise. Journal of Clinical Endocrinology and Metabolism 89: 3679-3684,2004.
     

    2005

  • Eisenhofer, G., F. Huysmans, K. Pacak, M.M. Walther, F.C.G.J Sweep and J.W.M. Lenders. Plasma metanehrines in renal failure. Kidney International 67: 668-677, 2005.
  • Eisenhofer, G., J.W.M. Lenders, D.S. Goldstein, M. Mannelli, G. Csako, M.M. Walther, F.M. Brouwers and K. Pacak. Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines. Clinical Chemistry 51: 735-744, 2005.
  • Eisenhofer, G., D.S. Goldstein, P. Sullivan, G. Csako, F.M. Brouwers, E.W. Lai, K.T. Adams, and K. Pacak. Biochemical and clinical manifestations of dopamine-producing paragangliomas. Journal of Clinical Endocrinology and Metabolism 90: 2068-2075, 2005.
  • Eisenhofer, G. Sympathetic nerve function: assessment by radioisotope dilution analysis. Clinical Autonomic Research 15: 264-283, 2005.
  • Huynh, T.-T., K. Pacak, F.M. Brouwers, M.S. Abu-Asab, R.A. Worrell, M.M. Walther, A.G. Elkahloun, D.S. Goldstein, S. Cleary and G. Eisenhofer. Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2. European Journal of Endocrinology 153: 551-563, 2005.
  • Lenders, J.W.M, G. Eisenhofer, M. Mannelli and K. Pacak. Phaeochromocytoma. Lancet 366: 665-675, 2005.
  • Pacak, K., I. Ilias, K.T. Adams, and G. Eisenhofer. Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour. Journal of Internal Medicine 257: 60-68, 2005.
  • Singh, R,J., S.K. Grebe, B. Yue, A.L. Rockwood, J.C. Cramer, Z. Gombos and G. Eisenhofer. Precisely wrong? Urinary fractionated metanephrines and peer-based laboratory proficiency testing. Clinical Chemistry 51: 472-473, 2005.
  • Ohta, S., E.W. Lai, A.L. Pang, F.M. Brouwers, W-Y. Chan, G. Eisenhofer, R. de Krijger, L. Ksinantova, J. Breza, P. Blazicek, R. Kvetnansky, R.A. Wesley, and K. Pacak, Down-regulation of metastasis suppressor genes in malignant pheochromocytoma. International Journal of Cancer 114: 139-143, 2005.
  • Brouwers, F.M., E.F. Petricoin, L. Ksinantova, J. Breza, V. Rajapakse, S. Ross, D. Johann, M. Mannelli, B.L. Shulkin, R. Kvetnansky, G. Eisenhofer, M.M. Walther, B.A. Hitt, T.P. Conrads, T.D. Veenstra, D.P. Mannion, M.R. Wall, G.M. Wolfe, V.A. Fusaro, L.A. Liotta, and K. Pacak. Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma. Endocrine-Related Cancer 12: 263-272, 2005.
  • Cleary, S., F.M. Brouwers, G. Eisenhofer, K. Pacak, D.L. Christie, J. Lipski, A.R. McNeil and J. Phillips. Expression of the noradrenaline transporter and phenylethanolamine N-methyltransferase (PNMT) in normal human adrenal gland and pheochromocytoma. Cell and Tissue Research 322: 443-453, 2005.
  • Petersson, M, P. Friberg, G. Eisenhofer, G. Lambert, and B. Rundqvist. Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure. European Heart Journal 26: 906-913, 2005.
  • Sorensen, D.B., P.F. Johnsen, B.M. Bibby, A. Bottner, S.R. Bornstein, G. Eisenhofer, K. Pacak and A.K. Hansen. PNMT transgenic mice have an aggressiive phenotype. Hormone and Metabolism Research 37: 159-163, 2005.
      

    2006

  • Huynh, T.-T., K. Pacak, D.L. Wong, W.M. Linehan, D.S. Goldstein, A.G. Elkahloun, P.J. Munson and G. Eisenhofer. Transcriptional regulation of phenylethanolamine N-methyltransferase in pheochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2. Annals of the New York Academy of Sciences, 1073: 241-252, 2006.
  • Grossman, A., K. Pacak, A. Sawka, J.W.M. Lenders, D. Harlander, R.T. Peaston, R. Reznek, J. Sisson and G. Eisenhofer. Biochemical diagnosis and localization of pheochromocytoma: Can we reach a consensus? Annals of the New York Academy of Sciences, 1073, 332-347, 2006.
  • Kasperlik-Zaluska AA, E. Roslonowska, J. Slowinska-Srzednicka, M. Otto, A. Cichocki  J. Cwikla, R. Slapa and G. Eisenhofer. 1111 Patients with Adrenal Incidentalomas Observed at a Single Endocrinological Centre: Incidence of Chromaffin Tumors. Annals of the New York Academy of Sciences 1073: 38-46, 2006.
  • Brouwers, F.M., A.G. Elkahloun, P.J. Munson, G. Eisenhofer, J. Barb, W.M. Linehan, J.W.M. Lenders, R. de Krijger, M. Mannelli, R. Udelsman, I.T. Ocal, B.L. Shulkin, S.R. Bornstein, J. Breza, L. Ksinantova and K. Pacak. Gene expression profiling of benign and malignant pheochromocytoma. Annals of the New York Academy of Sciences 1073: 541-556, 2006.
  • Elkahloun A.G., J.F. Powers, A. Nyska, G. Eisenhofer and A.S. Tischler. Gene-expression Profiling of Rat Pheochromocytomas. Annals of the New York Academy of Sciences 1073: 290-299, 2006.
  • Chidakel, A.R., K. Pacak, G. Eisenhofer, J. Lawerence and A.R. Ayala. The utility of plasma metanephrines in the diagnosis of factitious pheochromocytoma. Endocrine Practice 12:568-71, 2006.
  • Eisenhofer, G. Pheochromocytoma: Recent advances and obstacles to future progress. Journal of Hypertension 24: 2341-2343, 2006.
  • Brouwers, F.M., G. Eisenhofer, J.J. Tao, J.A. Kant, K.T. Adams, W.M. Linehan and K. Pacak. High Frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: Implications for genetic testing. Journal of Clinical Endocrinology and Metabolism 91:4505-4509, 2006.
  • Goldstein, D.S., G. Eisenhofer and I.J. Kopin. Clinical Catecholamine Neurochemistry: A Legacy of Julius Axelrod. Cellular and Molecular Neurobiology 26: 693-700, 2006.
  • Brouwers, F.M., G. Eisenhofer, J.W. Lenders and K. Pacak. Emergencies caused by pheochromocytoma, neuroblastoma, or ganglioneuroma. Endocrinology and Metabolism Clinics of North America 35: 699-724, 2006.
     

    2007

  • Pacak, K., G. Eisenhofer, H. Ahlman, S.R. Bornstein, A.P. Gimenez-Roqueplo, A.B. Grossman, N. Kimura, M. Mannelli, A.M. McNicol and A.S. Tischler. Pheochromocytoma: recommendations for clinical practice from the first international symposium. Nature: Clinical Practice, Endocrinology & Metabolism 3: 92-102, 2007.
  • Lenders, J.W.M., J.J. Willemsen, G. Eisenhofer, H.A. Ross, K. Pacak, H.J.L.M. Timmers, and C.G.J. Sweep. Is supine rest necessary before blood sampling for plasma metanephrines? Clinical Chemistry 53: 352-354, 2007.
  • Scholz, T., G. Eisenhofer, K. Pacak K, H. Dralle, and H. Lehnert. Current Treatment of Malignant Pheochromocytoma. Journal of Clinical Endocrinology & Metabolism. 92:1217-1225, 2007.
  • Singh RJ, and G. Eisenhofer. High-throughput, automated, and accurate biochemical screening for pheochromocytoma: are we there yet? Clinical Chemistry 53:1565-1567, 2007.
  • Timmers, H.J.L.M., A. Kozupa1, G. Eisenhofer, M. Raygada, K.T. Adams, D. Solis, J.W.M. Lenders and K. Pacak. Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with SDHB-associated pheochromocytomas and paragangliomas. Journal of Clinical Endocrinology and Metabolism 92: 779-786, 2007.
    Cleary, S., J.K. Phillips, T-T Huynh, K. Pacak, A.G. Elkahloun, J. Barb, R.A. Worrell, D.S. Goldstein and G. Eisenhofer. Neuropeptide Y expression in phaeochromocytomas: Relative absence in tumours from patients with von Hippel-Lindau syndrome. Journal of Endocrinology 193: 225-233, 2007.
  • Timmers, H.J.L.M., A. Kozupa, C.C. Chen, J.A. Carrasquillo, A. Ling, G. Eisenhofer, K.T. Adams, D. Solis, J.W.M. Lenders and K. Pacak. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. Journal of Clinical Oncology 25:2262-9, 2007.
  • Eisenhofer, G., G. Rivers, A.L. Rosas, Z. Quezado, W.M. Manger and K. Pacak. Adverse drug reactions in phaeochromocytoma: Incidence, prevention and management. Drug Safety 30:1031-1062, 2007.
  • Brouwers, F.M., S. Gläsker, A.F. Nave, A.O. Vortmeyer, I. Lubensky, S. Huang, M.S. Abu-Asab, G. Eisenhofer, R.J. Weil, D.M. Park, W.M. Linehan, K. Pacak, and Z. Zhuang. Proteomic Profiling of VHL and MEN2 Pheochromocytomas Reveals Different Expression of Chromogranin B. Endocrine-Related Cancer 14: 463-471. 2007.
  • Goldstein, D.S., Y. Sharabi, B.I. Karp, O. Bentho, A. Saleem, K. Pacak, and G. Eisenhofer. Cardiac sympathetic denervation preceding motor signs in Parkinson disease. Clinical Autonomic Research 17:118-121, 2007.
  • Kaji P., J.A. Carrasquillo, W.M. Linehan, C.C. Chen, G. Eisenhofer, P.A. Pinto, E.W. and K. Pacak. The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome. European Journal of Endocrinology 156: 483-487, 2007.
  • Zelinka, T., G. Eisenhofer, and K. Pacak, Pheochromocytoma as a catecholamine producing tumor: Implications for clinical practice. Stress 10: 195-203, 2007.
  • Pacak K., G. Eisenhofer, and A. Grossman. The incidentally discovered adrenal mass (letter to the editor). New England Journal of Medicine 356:2005, 2007.
  • Pacak K, Eisenhofer G. An assessment of biochemical tests for the diagnosis of pheochromocytoma. Nature: Clinical Practice, Endocrinology & Metabolism “in press” 2007.
  • Green-golan, L., C. Yates, B. Drinkard, C. Vanryzin, G. Eisenhofer, M. Weise, and D.P. Merke. Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glycemic control during prolonged moderate-intensity exercise. Journal of Clinical Endocrinology and Metabolism 92: 3019-3024, 2007.
  • Cleary, S., J.K. Phillips, T.-T. Huynh, K. Pacak, S. Fliedner, A.G. Elkahloun, P. Munson, R.A. Worrell and G. Eisenhofer. Chromogranin A expression in phaeochromocytomas associated with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2. Hormone and Metabolism Research 39; 876-83, 2007.
  • Sharabi, Y., D. Goldstein, O. Bentho, A. Saleem, S. Pechnik, M.F. Geraci, C. Holmes, K. Pacak, and G. Eisenhofer. Sympathoadrenal function in patients with paroxysmal hypertension — pseudopheochromocytoma. Journal of Hypertension 25: 2286-2295, 2007.
  • Eisenhofer, G., Y. Sharabi and K. Pacak. Unexplained symptomatic hypertension in pseudopheochromocytoma: A stress response disorder. Annals of the New York Academy of Sciences, 'in press'.

2008

  • Eisenhofer, G., T.T. Huynh, A. Elkahloun, J.C. Morris, G. Bratslavsky, W.M. Linehan, Z. Zhuang, B.M. Balgley, C.S. Lee, M. Mannelli, J.W.M. Lenders, S.R. Bornstein and K. Pacak. Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma. American Journal of Physiology: Endocrinology & Metabolism 295: ‘in press”, 2008.
  • Timmers H.J., K. Pacak, T.T. Huynh, M. Abu-Asab, M. Tsokos, M.J. Merino, B.E. Baysal, K.T. Adams, and G. Eisenhofer. Biochemically silent abdominal paragangliomas in patients with mutations of the SDHB gene. Journal of Clinical Endocrinology and Metabolism “in press” 2008.
  • Rosas, A.L., A.A. Kasperlik-Zaluska, L. Papierska, B.L. Bass, K. Pacak, and G. Eisenhofer. Pheochromocytoma crisis induced by glucocorticoids: a report of four cases and review of the literature. European Journal of Endocrinology 158: 423-429, 2008.
  • Eisenhofer, G., G. Siegert, J. Kotzerke, S. Bornstein, and K. Pacak. Current progress and future challenges in the biochemical diagnosis and treatment of phaeochromocytomas and paragangliomas. Hormone and Metabolism Research 40: 329-337, 2008.
  • Timmers, H.J., K. Pacak, J. Bertherat, J.W. Lenders, M. Duet, G. Eisenhofer, C.A. Stratakis, P. Niccoli-Sire, P.T. Huy, N. Burnichon and A.P. Gimenez-Roqueplo. Mutations associated with succinate dehydrogenase D-related malignant paragangliomas. Clinical Endocrinology (Oxf) 68: 561-566, 2008.
  • Zelinka, T., H.J. Timmers, A. Kozupa, C.C. Chen, J.A. Carrasquillo, J.C. Reynolds, A. Ling, G. Eisenhofer, I. Lazúrová, K.T. Adams, M.A. Whatley, J. Widimsky Jr and K Pacak. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations. Endocrine Related Cancer. 15:311-323, 2008
  • Havekes, B., J.A. Romijn, G. Eisenhofer, K. Adams and K. Pacak. Update on pediatric pheochromocytoma. Pediatric Nephrology “in press” 2008.
  • Zöphel, K., A. Strumpf, G. Wunderlich, L. Oehme, G. Eisenhofer, and J. Kotzerke. Cure of Neuroendocrine Carcinoma by Peptide Receptor Radionuclide Therapy. Clinical Nuclear Medicine 33: 690-691, 2008.
  • Menschikowski, M., A. Hagelgans, H. Kostka, G. Eisenhofer, and G. Siegert. Involvement of epigenetic mechanisms in the regulation of secreted phospholipase A2 expressions in Jurkat leukemia cells. Neoplasia. 10: 1195-1203, 2008.
  • Eisenhofer, G., Y. Sharabi and K. Pacak. Unexplained symptomatic hypertension in pseudopheochromocytoma: A stress response disorder. Annals of the New York Academy of Sciences, ‘in press’, 2008.
  • Kantorovich, V., G. Eisenhofer and K. Pacak. Pheochromocytoma: an endocrine stress mimicking disorder. Annals of the New York Academy of Sciences, ‘in press’', 2008.
  • Thouënnon, E., A. Pierre, J. Guillemot, L. Yon, G. Eisenhofer and Y. Anouar. Genetic Markers for the diagnosis and prognosis of pheochromocytoma. Expert Review of Endocrinology & Metabolism ‘in press’, 2009.

 

nach oben